Efficacy of intra-peritoneal administration of metformin and 5-fluoruracil in prevention of induced-colorectal aberrant crypt foci in mice

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 6, Issue 2, 2014, Pages 305-308

  Abdulkareem, H Abd ^a   Hussein, Alaa Ghani ^a   Mahmood, Ahmed Salim ^b  

^a Al Nahrain University College of Medicine   (Iraq)

^b UNIVERSITY OF ANBAR   (Iraq)

Author keywords

5 Fluorouracil; Aberrant crypt foci; Chemoprevention; Metformin

Indexed keywords

AZOXYMETHANE; CYCLINE; FLUOROURACIL; METFORMIN; METHYLENE BLUE;

ABERRANT CRYPT FOCUS; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BODY WEIGHT; CELL DIFFERENTIATION; CHEMOPROPHYLAXIS; COLON; COLORECTAL CANCER; CONTROLLED STUDY; EPITHELIUM; FEMALE; GLUCOSE BLOOD LEVEL; GOBLET CELL; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN;

EID: 84897142898     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Jemal A, Siegel R., Ward E, Jiaquan Xu. Cancer Statistics, 2010. CA CANCER J. CLIN. 2010; 60: 277-300.
2. Gupta RA, Dubois RN. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer 2001; 1: 11-21.
3. Gwyn K, Sinicrope FA. Chemoprevention of colorectal cancer. Am J Gastroenterology 2002; 97: 13-21.
4. Psaty BM, Furberg CD. COX-2 inhibitors-lessons in drug safety. Engl J Med 2005; 352: 1133-1135.
5. Shaw RJ, Lamina KA, Vasquez D. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 2005; 310: 1642-1646.
6. Bowker SL, Majumdar SR, Veugelers P & Johnson JA. Increased cancer-related mortality 11 for patients with type 2 diabetes who use sulfonylurea or insulin. Diabetes Care 2006; 29 254-258.
7. Evans JM, Donnelly LA, Emslie-Smith AM, Alessi DR & Morris AD. Metformin and 36 reduced risk of cancer in diabetic patients. BMJ 2005; 330: 1304-1305.
8. Memmott R. M, Mercado J. R., Maier C. R., Kawabata S., Fox S. D., Dennis P. A. Metformin Prevents Tobacco Carcinogen-Induced Lung Tumor genesis. Cancer Prev Res 2010; 3(9); 1066-76.
9. Hosono K., Endo H., Takahashi H. Metformin Suppresses Azoxymethane-Induced Colorectal Aberrant Crypt Foci by Activating AMP-Activated Protein Kinase. Molecular Carcinogenesis 2010; 49: 662-671.
10. Goodwin P J, Ligibel J A., and Stambo V. Metformin in Breast Cancer: Time for Action. Journal of Clinical Oncology 2009; 27: 3271-3273.
11. Ben Sahra I., Laurent K., Loubat A. et al. The antidaibetic drug meftromin exerts an antitumor effect in vitro and in vivo through a decrease of cyclin D1 level. Oncogene 2008; 27: 3576-3586.
12. McLellan, E A., and Bird, R P. Aberrant crypts: Potential reneoplastic lesions in the murine colon. Cancer Res 1988; 48: 6187-6192.
13. Pretlow, T. P., O'Riordan, M. A., Pretlow, T. G., and Stellato, T. A. Aberrant crypts in human colonic mucosa: Putative preneoplastic lesions. J. Cell Biochem. Suppl. 1992; 16G: 55-62.
14. Janne PA, Mayer RJ. Chemoprevention of colorectal cancer. Engl J Med 2000; 342: 1960-8.
15. Rozen P, Samuel Z, Shomrat R. Notable interfamilial phenotypic variability in a kindred with familial adenomatous polyposis and an APC mutation in exon 9, Gut 1999; 45: 829-833.
16. Bird P. R. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer letter1995; 93: 55-71.
17. Takayama T., Katsuki S., Takahashi Y. Aberrant crypt foci of the colon as precursors of adenoma and cancer. Engl J Med. 1998; 339: 1277-1284.
18. Michael J. Aberrant crypts as biomarker for colon cancer: Evaluation of potential chemopreventive agent in the rat. Cancer Epidemiology, Biomarkers and Prevention1996; 5: 335-360.
19. Maga G. and Hubshcer U. Proliferating cell nuclear antigen (PCNA): A dancer with many partners. Journal of Cell scinence2003; 116: 3051-3060.
20. Snorgaard O., Kober L., Carlsen J. The effect of metformin on blood pressure and metabolism in nondiabetic hypertensive patient. Journal of Internal Medicine 1997; 242: 407-412.
21. Feng JP, Chen JG, Yuan XL. Impact of 5-fluorouracil on glucose metabolism and pancreatic pathology in rats. Chinese journal of gastrointestinal surgery 2010; 13: 935-938.
22. Zhou G, Myers R, Li Y. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest2001; 108: 1167-1174.
23. ZHOU Xiao-zhi, XUE Yao-ming, ZHU Bo, SHA Jian-ping. Effects of Metformin on proliferation of human colon carcinoma cell line SW-480, J South Med Univ 2010; 30(8): 1935-1942.